Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

20

Revenue 2017

Triumeq

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Triumeq was produced by GlaxoSmithKline.

GSK two-drug trial in untreated HIV raises Gilead rivalry

GSK two-drug trial in untreated HIV raises Gilead rivalry years due to the success of drugs like Tivicay and triple regimen Triumeq (dolutegravir/lamivudine/abacavir).

ART Perspectives

Triumeq. and ultimately improving outcomes. ART Perspectives was debuted in Mexico, a key market where Triumeq.

CHMP backs first-line use for AZ’s Tagrisso in lung cancer

CHMP backs first-line use for AZ’s Tagrisso in lung cancer to Triumeq (abacavir/dolutegravir/lamivudine), currently spearheading a gain in HIV market share for Viiv. ... Gilead reported new data last month showing that it was possible to switch from Triumeq to Biktarvy with no loss of efficacy and - it claims -

Morning brief: Allergan’s migraine results, Biktarvy approved in Europe and more

Morning brief: Allergan’s migraine results, Biktarvy approved in Europe and more the US, analysts say the drug combination is already gaining market share from GSK’s Triumeq and Tivicay.

Gilead says switching studies back new HIV therapy Biktarvy

Gilead says switching studies back new HIV therapy Biktarvy Patients who switched from rival Triumeq could maintain viral suppression over the trial period. ... Both Biktarvy and Triumeq are fixed-dose triple therapies for HIV delivered once-daily, and competition in the marketplace is expected to be fierce.

[ Previous 5 results ] 1 2 3 4 5 6 7 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

The search for treatments for Parkinson’s disease
The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...
Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
Ditch the Label – it’s just me....
The impact of COVID-19 on clinical trials
As all industry sectors work to assess both the impact and the optimal path forward, the effects are expected to be diverse and long-lasting...

Infographics